COMP <GO>
PRPO vs UNH // REVENUE GROWTH (YOY)
Precipio Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: PRPO 2
— UNH 9
▲ REVENUE GROWTH (YOY) LEADER: PRPO
LAST: $17.79 (-1.71%) • MKT CAP: $31.8M
revenue-growth
30.50%
LAST: $400.44 (-1.60%) • MKT CAP: $359.43B
revenue-growth
3.33%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PRPO VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PRPO | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 44.20% | 88.31% | -44.11 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -7.90% | 12.38% | -20.28 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 1.04% | 6.25% | -5.21 | UNH | /fcf-yield <GO> |
| Operating Margin | -5.00% | 5.32% | -10.32 | UNH | /operating-margins <GO> |
| Net Profit Margin | -1.50% | 3.53% | -5.03 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 30.50% | 3.33% | +27.17 | PRPO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.29% | -2.29 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 3.09 | -2.89 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | PRPO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 30.2 | 55.1 | -24.90 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 17.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $31.8M | $359.43B | -$359.40B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PRPO REV | UNH REV | PRPO GROSS % | UNH GROSS % | PRPO FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $24.2M | $447.57B | 44.2% | 88.7% | $359.0K | $16.07B |
| FY 2024 | $18.6M | $400.28B | 40.7% | 88.3% | $216.0K | $20.70B |
| FY 2023 | $15.4M | $371.62B | — | 89.6% | -$3.6M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PRPO // BETA —
UNH // BETA 0.33